Compare CVRX & AUBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVRX | AUBN |
|---|---|---|
| Founded | 2000 | 1907 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.3M | 92.5M |
| IPO Year | 2021 | 1996 |
| Metric | CVRX | AUBN |
|---|---|---|
| Price | $2.57 | $26.81 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $10.50 | N/A |
| AVG Volume (30 Days) | ★ 541.2K | 1.3K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 4.61% |
| EPS Growth | ★ 23.02 | 13.66 |
| EPS | N/A | ★ 1.29 |
| Revenue | ★ $56,651,000.00 | $619,000.00 |
| Revenue This Year | $17.17 | N/A |
| Revenue Next Year | $17.69 | N/A |
| P/E Ratio | ★ N/A | $21.10 |
| Revenue Growth | ★ 10.45 | 0.81 |
| 52 Week Low | $2.20 | $21.60 |
| 52 Week High | $11.30 | $28.88 |
| Indicator | CVRX | AUBN |
|---|---|---|
| Relative Strength Index (RSI) | 35.30 | 61.11 |
| Support Level | $2.20 | $24.10 |
| Resistance Level | $3.19 | $27.77 |
| Average True Range (ATR) | 0.19 | 0.49 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 9.68 | 58.59 |
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Auburn National Bancorp Inc is a bank holding company registered with the Board of Governors of the Federal Reserve System (the Federal Reserve). As a bank holding company, the Company may diversify into a broader range of financial services and other business activities than are currently permitted to the Bank under applicable laws and regulations. The holding company structure also provides greater financial and operating flexibility than is presently permitted to the Bank. The Company's business is conducted through the Bank and its subsidiaries. Although it has no immediate plansto conduct any other business, the Company may engage directly or indirectly in several activities closely related to banking permitted by the Federal Reserve.